Single-Arm Phase II Study of Stereotactic Body Radiation Therapy Concurrent With Nelfinavir for Oligometastases
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2018
Price : $35 *
At a glance
- Drugs Nelfinavir (Primary)
- Indications Cancer metastases
- Focus Therapeutic Use
- 20 Jul 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2020.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2013 Planned initiation date changed from 1 Feb 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.